GlobeNewswire 12-08 Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
GlobeNewswire 12-08 Initial admission to the Official List
GlobeNewswire 12-08 ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti...
GlobeNewswire 12-08 OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development
GlobeNewswire 12-08 Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
GlobeNewswire 12-07 ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ...
GlobeNewswire 12-05 Dividend Declaration
GlobeNewswire 12-05 SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
GlobeNewswire 12-05 Stellantis’ Shares to Win Employee Purchase Plan Reaches 22 Million Shares Subscribed in Over Three ...
GlobeNewswire 12-05 ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting
GlobeNewswire 12-05 Result of AGM for 2025
GlobeNewswire 12-04 JDE Peet’s prices EUR 600 million senior unsecured notes issue
GlobeNewswire 12-04 Participation notification by UBS Group AG
GlobeNewswire 12-04 New Year. New Century. New Wishes.
GlobeNewswire 12-04 Telenor Marks 25 Years on the Oslo Stock Exchange
GlobeNewswire 12-04 Press Release: Sanofi completes acquisition of Vicebio
GlobeNewswire 12-04 Biggest Office Party Night of the Year Set for Unprecedented Surge in 0.0 Drinking
GlobeNewswire 12-04 Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
GlobeNewswire 12-03 THEON and Exosens announce extension of Long-Term Commercial Agreement for Image Intensifier Tube Su...
GlobeNewswire 12-03 No Excuses Needed: the 2025 Festive Season Marks the First Where Saying ‘No Thanks’ to Alcohol Won’t...
GlobeNewswire 12-03 Nedap and iLOQ announce strategic technology partnership for future-proof access solutions
GlobeNewswire 12-03 Quadient Enters Agreement to Acquire CDP Communications, Bolstering Number 1 Market Share Position f...
GlobeNewswire 12-03 Signify completes cancellation of 5.8 million shares
GlobeNewswire 12-02 dsm-firmenich completes €1.08 billion share repurchase program
GlobeNewswire 12-02 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as...